Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $482,806 - $1.02 Million
-15,154 Reduced 59.92%
10,136 $439,000
Q1 2023

May 17, 2023

SELL
$45.44 - $74.26 $85,790 - $140,202
-1,888 Reduced 6.95%
25,290 $1.66 Million
Q4 2022

Mar 06, 2023

SELL
$41.39 - $81.0 $3.37 Million - $6.59 Million
-81,418 Reduced 74.97%
27,178 $1.22 Million
Q3 2022

Nov 02, 2022

SELL
$72.36 - $113.1 $2.26 Million - $3.54 Million
-31,288 Reduced 22.37%
108,596 $7.86 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $4.1 Million - $5.36 Million
47,015 Added 50.63%
139,884 $15 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $5.48 Million - $7.24 Million
58,135 Added 167.37%
92,869 $10.3 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $914,949 - $1.06 Million
7,652 Added 28.25%
34,734 $4.45 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $1.64 Million - $2.13 Million
14,980 Added 123.78%
27,082 $3.6 Million
Q2 2021

Aug 10, 2021

BUY
$100.34 - $115.69 $374,870 - $432,217
3,736 Added 44.66%
12,102 $1.31 Million
Q1 2021

May 11, 2021

BUY
$101.51 - $125.27 $266,463 - $328,833
2,625 Added 45.72%
8,366 $880,000
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $450,182 - $552,297
5,242 Added 1050.5%
5,741 $597,000
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $249,425 - $317,182
-3,429 Reduced 87.3%
499 $42,000
Q2 2020

Aug 12, 2020

SELL
$48.02 - $79.04 $3,169 - $5,216
-66 Reduced 1.65%
3,928 $288,000
Q1 2020

May 12, 2020

SELL
$36.95 - $62.95 $15,445 - $26,313
-418 Reduced 9.47%
3,994 $208,000
Q4 2019

Feb 07, 2020

SELL
$47.06 - $56.64 $21,835 - $26,280
-464 Reduced 9.52%
4,412 $249,000
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $41,234 - $50,445
869 Added 21.69%
4,876 $233,000
Q2 2019

Aug 09, 2019

BUY
$39.26 - $54.21 $127,673 - $176,290
3,252 Added 430.73%
4,007 $217,000
Q1 2019

May 10, 2019

BUY
$29.84 - $43.92 $22,529 - $33,159
755 New
755 $31,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.